In vitro and in vivo studies of galactose-modified liver-targeting liposomes

References

• Allen TM, Hansen CB, Meneze DE. (1995). Pharmacokinetics of longcirculating liposomes. Adv Drug Deliv Rev, 16, 267–284.
   Web of Science ®Google Scholar
• Batzri S, Korn ED. (1973). Single bilayer liposomes prepared without sonication. Biochim Biophys Acta, 298, 1015–1019.
   PubMed Web of Science ®Google Scholar
• Chen ZP, Zhu JB, Chen HX, Xiao YY, Chen J, Cai BC. (2010). Distribution of liposomal bifendate in liver following intravenous injection in mice. J Drug Target, 18, 627–636.
   PubMed Web of Science ®Google Scholar
• Chiu GN, Bally MB, Mayer LD. (2003). Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis. Biochim Biophys Acta, 1613, 115–121.
   PubMed Web of Science ®Google Scholar
• Cortesi R, Esposito E, Cuccu I, Romagnoli R, Menegatti E, Zaid AN, Nastruzzi C. (2007). Liposomes and micellar dispersions for delivery of benzoheterocyclic derivatives of distamycin A. Drug Deliv, 14, 1–8.
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. (2004). Methoxy poly(ethylene glycol)-poly(lactide) (MnPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 25, 2843–2849.
   PubMed Web of Science ®Google Scholar
• Dube D, Khatri K, Goyal AK, Mishra N, Vyas SP. (2010). Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm, 36, 547–555.
   PubMed Web of Science ®Google Scholar
• Fujita E, Nagao Y, Node M, Kaneko K, Nakazawa S, Kuroda H. (1976). Antitumor activity of the Isodon diterpenoids: Structural requirements for the activity. Experientia, 32, 203–206.
   PubMedGoogle Scholar
• Guan YZ, Wei TH. (2005). Clinical research on the oridonin injection for the interventional therapy of liver cancer. J Med Radiol Technol, 236–243.
   Google Scholar
• Guo BH, Cheng Y, Lin LP, Lin DH, Wu W. (2011). Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction. J Liposome Res, 21, 255–260.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT. (1989). Quantitative evaluation of targeted drug delivery systems. Int J Pharm, 56, 217–226.
   Web of Science ®Google Scholar
• Henan Medical Institute, Henan Medical College, Yunnan Institute of Botany. (1978). Oridonin: A new antitumor subject. Chin Sci Bull, 23, 53–56.
   Google Scholar
• Korba BA, Xie H, Wright KN, Hornbuckle WE, Gerin JL, Tennant BC, Hostetler KY. (1996). Liver-targeted antiviral nucleosides: Enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo. Hepatology, 23, 958–963.
   PubMed Web of Science ®Google Scholar
• Lee JS, Chung D, Lee HG. (2008). Preparation and characterization of calcium pectinate gel beads entrapping catechin-loaded liposomes. Int J Biol Macromol, 42, 178–184.
   PubMed Web of Science ®Google Scholar
• Nagayas A, Uchiyama K, Kiwada H. (1999). The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev, 40, 75–87.
   PubMed Web of Science ®Google Scholar
• Shah VP, Midha KK, Findlay JW, Hill H. M, Hulse JD, McGilveray J, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. (2000). Bioanalytical method validation--a revisit with a decade of progress. Pharm Res, 17, 1551–1557.
   PubMedGoogle Scholar
• Shimizu K, Maitani Y, Takayama K, Nagai T. (1996). Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting. J Drug Target, 4, 245–253.
   PubMed Web of Science ®Google Scholar
• Sonoke S, Ueda T, Fujiwara K, Kuwabara K, Yano J. (2011). Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA. Biol Pharm Bull, 34, 1338–1342.
   PubMed Web of Science ®Google Scholar
• Srinath P, Chary MG, Vyas SP, Diwan PV. (2000). Long-circulating liposomes of indomethacin in arthritic rats–a biodisposition study. Pharm Acta Helv, 74, 399–404.
   PubMedGoogle Scholar
• Sun W, Zou W, Huang G, Li A, Zhang N. (2008). Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target, 16, 357–365.
   PubMed Web of Science ®Google Scholar
• Sun Q, Shi M, Shao W, Shi Y, Xi Y, Huang G. (2011). Tissue distribution and pulmonary targeting studies of cefpiramide sodium-loaded liposomes. J Drug Target, 19, 49–55.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Kojima H, Toyoda T, Yamamoto H, Hino T ,Kawashima Y. (1999). Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intra- venous injection in rats. Eur J Pharm Biopharm, 48, 123–129.
   PubMed Web of Science ®Google Scholar
• Uchida T, Serizawa T, Ise H, Akaike T, Akashi M. (2001). Graft copolymer having hydrophobic backbone and hydrophilic branches. 33. Interaction of hepatocytes and polystyrene nanospheres having lactose-immobilized hydrophilic polymers on their surfaces. Biomacromolecules, 2, 1343–1346.
   PubMed Web of Science ®Google Scholar
• Wang S, Xu H, Xu J, Zhang Y, Liu Y, Deng YH, Chen D. (2010). Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid. AAPS PharmSciTech, 11, 870–877.
   PubMed Web of Science ®Google Scholar
• Wang SL, Yu FB, Jiang TY, Sun CS, Wang T, Zhang JH. (2008). Design and synthesis of novel galactosylated polymers for liposomes as gene drug carriers targeting the hepatic asialoglycoprotein receptor. J Drug Target, 16, 233–242.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Han QB, Zhao AH, Sun HD. (2003). Diterpenoids from Isodon japonica. Fitoterapia, 74, 435–438.
   PubMed Web of Science ®Google Scholar